Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/10/1994 | CA2160909A1 Cell-targeted lytic pore-forming agents |
11/10/1994 | CA2160703A1 Method of separating glycosylated and non-glycosylated proteins |
11/10/1994 | CA2159716A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage |
11/10/1994 | CA2159508A1 Method of enhancing thrombolysis |
11/10/1994 | CA2159323A1 Dna segment comprising gene encoding insecticidal protein |
11/10/1994 | CA2136734A1 Purification method for hydrophobic polypeptide |
11/09/1994 | EP0623679A1 Targeted multifunctional proteins |
11/09/1994 | EP0623676A1 Metalloproteinase inhibitor |
11/09/1994 | EP0623674A1 Interleukin-1 receptors |
11/09/1994 | EP0623628A1 Muscular dystrophy gene products, antibodies thereto and methods for immunodiagnosis of muscular dystrophy |
11/09/1994 | EP0623606A2 Peptidic ketones as interleukin-1beta-converting enzyme inhibitors |
11/09/1994 | EP0623592A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors |
11/09/1994 | EP0623352A2 Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumorselective therapy |
11/09/1994 | EP0623216A1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS |
11/09/1994 | EP0623215A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
11/09/1994 | EP0623173A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
11/09/1994 | EP0623172A1 Marek's disease virus recombinant poxvirus vaccine |
11/09/1994 | EP0623170A1 Vaccines based on streptokinase |
11/09/1994 | EP0623169A1 Hepatitis e virus vaccine and method |
11/09/1994 | EP0623168A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
11/09/1994 | EP0623147A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus |
11/09/1994 | EP0623146A1 COMPOUNDS AND METHODS FOR INHIBITING $g(b)-PROTEIN FUNCTION |
11/09/1994 | EP0623144A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
11/09/1994 | EP0623142A1 Mammalian adipogenic factors |
11/09/1994 | EP0623025A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
11/09/1994 | EP0477217B1 Stabilized, potent grf analogs |
11/09/1994 | EP0460217B1 cDNA OF ORSV GENE |
11/09/1994 | EP0420894B1 Large scale method for purification of high purity heparinase |
11/09/1994 | EP0375718B1 Process for the production of aprotinin and aprotinin homologues in yeast |
11/09/1994 | EP0341287B1 Diagnostic methods and systems for quantifying apo ai |
11/09/1994 | EP0305500B1 Process for the purification of recombinant polypeptides |
11/09/1994 | EP0152477B1 Polypeptide-induced monoclonal antibodies to oncoproteins |
11/09/1994 | CN1094642A Therapeutic combination |
11/09/1994 | CN1094640A Urease-based vaccine against helicobacter infection |
11/09/1994 | CN1094609A Anticaries compositions |
11/09/1994 | CN1026497C Insect-resistant plants |
11/08/1994 | US5362865 Enhanced expression in plants using non-translated leader sequences |
11/08/1994 | US5362864 Trans-activating factor-1 |
11/08/1994 | US5362857 Purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography |
11/08/1994 | US5362856 Monooxygenase-like activity of heme proteins |
11/08/1994 | US5362855 Imidoester cross-linked hemoglobin compositions |
11/08/1994 | US5362854 Complexes |
11/08/1994 | US5362853 Polypeptide derivatives of human granulocyte colony stimulating factor |
11/08/1994 | US5362852 Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties |
11/08/1994 | US5362716 Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
11/08/1994 | US5362644 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, method for preparing them and also their applications |
11/08/1994 | US5362641 Hydrolytic enzymes |
11/08/1994 | US5362631 Capable of producing granulocyte/macrophage-colony simulating factor |
11/08/1994 | US5362625 Methods and compositions for enzyme complementation assays using the omega region of β-galactosidase |
11/08/1994 | US5362623 Sequence specific DNA binding by p53 |
11/08/1994 | US5362490 Human myelomonocyte interferon-gamma, and process for preparation and use thereof |
11/08/1994 | US5362489 Lymphocytes |
11/08/1994 | CA2123055A1 Peptidic ketones as interleukin-1 beta-converting enzyme inhibitors |
11/08/1994 | CA1332998C Prostate-derived growth factor |
11/08/1994 | CA1332943C Process for preparing perhydrothiazepine derivatives |
11/03/1994 | DE4342132C1 Process for the preparation of virus-inactivated vitamin K-dependent plasma components, and protein C and protein S-containing compositions by membrane chromatography |
11/03/1994 | DE4314260A1 Peptides for the treatment of hypoglycaemia, process for the preparation thereof and the use thereof |
11/03/1994 | DE4313933A1 Functional receptor expression in Dictyostelium discoideum |
11/02/1994 | EP0622461A2 Preparation of yellow mosaic disease-resistant barley |
11/02/1994 | EP0622460A2 Plasmid and escherichia coli transformed with it |
11/02/1994 | EP0622459A1 Fused proteins for preparing vasoactive intestinal polypeptide analogs, method of preparing same and recombinant plasmids and transformant microorganisms |
11/02/1994 | EP0622458A2 Adrenomedullin |
11/02/1994 | EP0622456A1 Prokaryotic and eukaryotic vectors producing polypeptides containing epitopes of PDGF B |
11/02/1994 | EP0622377A2 Amphotropic virus receptor |
11/02/1994 | EP0622376A1 Amorphous monospheric forms of insulin derivatives |
11/02/1994 | EP0622375A1 Chrysospermines, peptide drugs from Apiocrea chrysosperma having pharmacological activity, process for their production, and their use |
11/02/1994 | EP0622084A1 Antibody-drug conjugates |
11/02/1994 | EP0622081A2 Epitopic regions of phneumococcal surface protein A |
11/02/1994 | EP0622080A2 Gelatinase A inhibitor |
11/02/1994 | EP0621902A1 Dna structure-specific recognition protein and uses therefor |
11/02/1994 | EP0621901A1 Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path |
11/02/1994 | EP0621899A1 Expression signal-peptide-free staphylokinases. |
11/02/1994 | EP0621898A1 Chimeric immunogens |
11/02/1994 | EP0621893A1 Feline leukemia virus vaccines |
11/02/1994 | EP0621875A1 Fibrinogen binding protein |
11/02/1994 | EP0621874A1 Somatostatin receptors |
11/02/1994 | EP0621873A1 A novel human kunitz-type protease inhibitor and variants thereof |
11/02/1994 | EP0621872A1 A human kunitz-type protease inhibitor variant |
11/02/1994 | EP0621868A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
11/02/1994 | EP0621790A1 Attenuated, live vaccine for delaware strain ibdv |
11/02/1994 | EP0621789A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
11/02/1994 | EP0621788A1 Hemoregulatory peptides |
11/02/1994 | EP0621780A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
11/02/1994 | EP0589961A4 Assay systems for neurotrophin activity. |
11/02/1994 | EP0587719A4 DETECTION OF COLLAGEN DEGRADATION -i(IN VIVO). |
11/02/1994 | EP0584283A4 Osteoinductive protein mixtures and purification processes. |
11/02/1994 | EP0578784A4 Odorant receptors ans uses thereof. |
11/02/1994 | EP0442961B1 Hybrid procoagulant proteins |
11/02/1994 | EP0398961B1 Polypeptide compounds having growth hormone releasing activity |
11/02/1994 | EP0382736B1 Receptor membranes |
11/02/1994 | EP0377659B1 Follistatin and method of purifying same |
11/02/1994 | EP0316378B1 Expression vector for adjustable expression of exogenous genes in prokaryotes |
11/02/1994 | CN1094446A ECK receptor ligands |
11/02/1994 | CN1094445A Fik-1 as receiptor of growth factor of blood vessel inner-skin |
11/02/1994 | CN1094411A Thymosin alpha-1 derivatives |
11/02/1994 | CA2122556A1 Dna fragment, vector containing the dna fragment, transformant transformed with the vector and process for producing protein using the vector |
11/01/1994 | US5360896 Glycosylated FGF |
11/01/1994 | US5360894 C/EBP2 gene and recombinant C/EBP2 |
11/01/1994 | US5360893 DNA sequences encoding proteins used to elicit and detect programmed cell death |
11/01/1994 | US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells |